glp 1 with b12 injection Compounded GLP-1 and insulin resistance GLP-1 and health: Beyond weight

Clinical trials conducted in the early 2000s showed modest results, and the compound failed to demonstrate sufficient efficacy to support regulatory approval as a weight-loss medicine

Not dramatic transformation, but the kind of change where waistband fit subtly shifts

Additionally, the final follow-up indicated no significant variation in the rates of excellent and good outcomes, suggesting that the initial therapeutic advantage conferred by dexamethasone and VB12 did not translate into superior long-term outcomes

These quality parameters are especially relevant in studies where inflammatory signaling or immune interference must be carefully controlled